DrugPatentWatch Database Preview
ZERVIATE Drug Profile
When do Zerviate patents expire, and when can generic versions of Zerviate launch?
Zerviate is a drug marketed by Eyevance and is included in one NDA. There are four patents protecting this drug.
This drug has fifteen patent family members in five countries.
The generic ingredient in ZERVIATE is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-four suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
Summary for ZERVIATE
| International Patents: | 15 |
| US Patents: | 4 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 74 |
| Patent Applications: | 4,121 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ZERVIATE at DailyMed |
Synonyms for ZERVIATE
| (2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic acid |
| (2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid |
| (2-{4-[(4-Chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid (2HCl) |
| [(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethyl)oxy]acetic acid |
| [2-[4-[(4-Chlorophenyl)-phenyl methyl]-1-piperazinyl] ethoxy] acetic acid |
| [2-[4-[(4-chlorophenyl)phenylmethyl] 1-piperazinyl]-ethoxy] acetic acid |
| [2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]-ethoxy]acetic acid |
| [2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid |
| 110271-EP2284166A1 |
| 110271-EP2298415A1 |
| 2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid |
| 2-(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid |
| 2-(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazino}ethoxy)acetic acid |
| 2-(2-{4-[(4-chlorophenyl)phenylmethyl]piperazinyl}ethoxy)acetic acid |
| 2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid |
| 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid |
| 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid |
| 24161-EP2272832A1 |
| 24161-EP2281815A1 |
| 24161-EP2295409A1 |
| 24161-EP2301933A1 |
| 24161-EP2305640A2 |
| 24161-EP2311827A1 |
| 24161-EP2314590A1 |
| 81C510 |
| 83881-51-0 |
| 83881-52-1 (di-hydrochloride) |
| A10107 |
| AB0019096 |
| AC-5545 |
| AC1L1E7T |
| AC1Q768B |
| Acetic acid, (2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)- |
| Acetic acid, [2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]- |
| AKOS003589059 |
| AKOS021729457 |
| Alerlisin |
| AN-10906 |
| AN-15756 |
| BBL009968 |
| BCP08787 |
| BCP28477 |
| BDBM22890 |
| Benaday |
| BPBio1_000469 |
| BRD-A42571354-300-05-4 |
| BRD-A42571354-300-07-0 |
| BSPBio_000425 |
| BSPBio_002302 |
| C-5854 |
| C07778 |
| C21H25ClN2O3 |
| CC0153 |
| Cetiderm (TN) |
| Cetirizin |
| Cetirizina |
| Cetirizina [Spanish] |
| cetirizine |
| Cetirizine (INN) |
| Cetirizine [INN:BAN] |
| CETIRIZINE HYDROCHLORIDE |
| CetirizineHydrochloride |
| Cetirizinum |
| Cetirizinum [Latin] |
| Cetrizide |
| Cetrizine Dihcl |
| Cetrizine Hcl |
| Cetryn |
| CHEBI:3561 |
| CHEMBL1000 |
| CPD001453715 |
| CS-0886 |
| CTK7J5576 |
| D07662 |
| DB00341 |
| DTXSID4022787 |
| EN300-52521 |
| FT-0603001 |
| FT-0654660 |
| GTPL1222 |
| Hitrizin Film Tablet |
| HMS1539O07 |
| HMS3259D06 |
| HMS3370I19 |
| HMS3393N10 |
| HSDB 7739 |
| HY-17042 |
| I06-0454 |
| J-005737 |
| L000655 |
| Levocetirizine HCl |
| LS-11409 |
| MCULE-8668839822 |
| MFCD00800721 |
| MolPort-002-506-309 |
| NC00696 |
| NCGC00167781-01 |
| NCGC00167781-02 |
| NCGC00167781-03 |
| NCGC00167781-04 |
| NCGC00167781-07 |
| Prestwick0_000503 |
| Prestwick1_000503 |
| Prestwick2_000503 |
| Prestwick3_000503 |
| RT-007014 |
| SAM002548972 |
| SAM002589989 |
| SBI-0206838.P001 |
| SC-17992 |
| SC-18167 |
| SC-19204 |
| SC-19390 |
| SCHEMBL4176 |
| Setir |
| SPBio_002346 |
| ST024755 |
| STK711108 |
| TimTec1_002075 |
| U095 |
| Virlix |
| Xarlin |
| Z1182332250 |
| Ziptek |
| Zirtek |
| ZKLPARSLTMPFCP-UHFFFAOYSA-N |
| Zyrlex |
| Zyrtec Syrup |
| Zyrtec-D |
US Patents and Regulatory Information for ZERVIATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eyevance | ZERVIATE | cetirizine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 208694-001 | May 30, 2017 | RX | Yes | Yes | See Pricing | See Pricing | See Pricing | ||||
| Eyevance | ZERVIATE | cetirizine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 208694-001 | May 30, 2017 | RX | Yes | Yes | See Pricing | See Pricing | Y | See Pricing | |||
| Eyevance | ZERVIATE | cetirizine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 208694-001 | May 30, 2017 | RX | Yes | Yes | See Pricing | See Pricing | Y | See Pricing | |||
| Eyevance | ZERVIATE | cetirizine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 208694-001 | May 30, 2017 | RX | Yes | Yes | See Pricing | See Pricing | Y | See Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ZERVIATE
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2408453 | See Pricing |
| Japan | 6144393 | See Pricing |
| Mexico | 2011009802 | See Pricing |
| World Intellectual Property Organization (WIPO) | 2011116020 | See Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ZERVIATE
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0663828 | C300085 | Netherlands | See Pricing | PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103 |
| 0058146 | 2001C/045 | Belgium | See Pricing | PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
